Arcadia Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $110K | Buy |
3,912
+12
| +0.3% | +$319 | 0.02% | 137 |
|
|
2025
Q4 | $97.1K | Hold |
3,900
| – | – | 0.02% | 150 |
|
|
2025
Q3 | $99.4K | Hold |
3,900
| – | – | 0.02% | 158 |
|
|
2025
Q2 | $94.5K | Hold |
3,900
| – | – | 0.02% | 159 |
|
|
2025
Q1 | $98.8K | Hold |
3,900
| – | – | 0.02% | 157 |
|
|
2024
Q4 | $103K | Hold |
3,900
| – | – | 0.02% | 164 |
|
|
2024
Q3 | $113K | Hold |
3,900
| – | – | 0.02% | 150 |
|
|
2024
Q2 | $109K | Sell |
3,900
-1,320
| -25% | -$36.3K | 0.02% | 153 |
|
|
2024
Q1 | $145K | Hold |
5,220
| – | – | 0.03% | 139 |
|
|
2023
Q4 | $150K | Sell |
5,220
-6,325
| -55% | -$191K | 0.03% | 144 |
|
|
2023
Q3 | $383K | Buy |
11,545
+1,000
| +9% | +$35.4K | 0.08% | 93 |
|
|
2023
Q2 | $387K | Sell |
10,545
-1,202
| -10% | -$46.8K | 0.08% | 97 |
|
|
2023
Q1 | $479K | Sell |
11,747
-6,591
| -36% | -$285K | 0.1% | 85 |
|
|
2022
Q4 | $940K | Hold |
18,338
| – | – | 0.22% | 72 |
|
|
2022
Q3 | $802K | Sell |
18,338
-4,055
| -18% | -$197K | 0.19% | 79 |
|
|
2022
Q2 | $1.17M | Sell |
22,393
-1,035
| -4% | -$52.7K | 0.26% | 68 |
|
|
2022
Q1 | $1.21M | Buy |
23,428
+364
| +2% | +$18.9K | 0.23% | 67 |
|
|
2021
Q4 | $1.36M | Buy |
23,064
+1,460
| +7% | +$72.3K | 0.23% | 74 |
|
|
2021
Q3 | $929K | Sell |
21,604
-625
| -3% | -$27.7K | 0.17% | 88 |
|
|
2021
Q2 | $870K | Sell |
22,229
-818
| -4% | -$31.8K | 0.16% | 88 |
|
|
2021
Q1 | $835K | Sell |
23,047
-242
| -1% | -$8.59K | 0.17% | 84 |
|
|
2020
Q4 | $857K | Sell |
23,289
-799
| -3% | -$29.3K | 0.18% | 78 |
|
|
2020
Q3 | $839K | Hold |
24,088
| – | – | 0.18% | 78 |
|
|
2020
Q2 | $747K | Buy |
24,088
+3,162
| +15% | +$107K | 0.18% | 75 |
|
|
2020
Q1 | $648K | Sell |
20,926
-1,054
| -5% | -$35.9K | 0.2% | 77 |
|
|
2019
Q4 | $817K | Buy |
21,980
+1,054
| +5% | +$37.5K | 0.21% | 75 |
|
|
2019
Q3 | $713K | Sell |
20,926
-1,991
| -9% | -$72.4K | 0.19% | 80 |
|
|
2019
Q2 | $942K | Sell |
22,917
-2,547
| -10% | -$101K | 0.26% | 72 |
|
|
2019
Q1 | $1.03M | Sell |
25,464
-12,734
| -33% | -$510K | 0.3% | 69 |
|
|
2018
Q4 | $1.58M | Sell |
38,198
-9,610
| -20% | -$399K | 0.53% | 52 |
|
|
2018
Q3 | $2M | Sell |
47,808
-2,123
| -4% | -$81.7K | 0.53% | 58 |
|
|
2018
Q2 | $1.72M | Sell |
49,931
-2,524
| -5% | -$86.3K | 0.48% | 61 |
|
|
2018
Q1 | $1.77M | Sell |
52,455
-1,207
| -2% | -$41.5K | 0.5% | 61 |
|
|
2017
Q4 | $1.84M | Sell |
53,662
-1,471
| -3% | -$50.2K | 0.52% | 60 |
|
|
2017
Q3 | $1.87M | Sell |
55,133
-685
| -1% | -$22K | 0.57% | 57 |
|
|
2017
Q2 | $1.78M | Sell |
55,818
-3,838
| -6% | -$121K | 0.56% | 56 |
|
|
2017
Q1 | $1.94M | Sell |
59,656
-754
| -1% | -$23.8K | 0.61% | 55 |
|
|
2016
Q4 | $1.86M | Sell |
60,410
-1,096
| -2% | -$33.5K | 0.61% | 59 |
|
|
2016
Q3 | $1.98M | Sell |
61,506
-1,444
| -2% | -$48.3K | 0.66% | 55 |
|
|
2016
Q2 | $2.1M | Buy |
62,950
+25,790
| +69% | +$823K | 0.69% | 55 |
|
|
2016
Q1 | $1.04M | Buy |
37,160
+274
| +0.7% | +$7.83K | 0.34% | 67 |
|
|
2015
Q4 | $1.13M | Buy |
36,886
+10,161
| +38% | +$320K | 0.35% | 66 |
|
|
2015
Q3 | $796K | Buy |
26,725
+958
| +4% | +$30.7K | 0.24% | 74 |
|
|
2015
Q2 | $819K | Buy |
25,767
+7,647
| +42% | +$249K | 0.21% | 77 |
|
|
2015
Q1 | $598K | Sell |
18,120
-21,074
| -54% | -$670K | 0.17% | 81 |
|
|
2014
Q4 | $1.16M | Buy |
39,194
+720
| +2% | +$20.6K | 0.33% | 72 |
|
|
2014
Q3 | $1.08M | Hold |
38,474
| – | – | 0.32% | 68 |
|
|
2014
Q2 | $1.08M | Sell |
38,474
-211
| -0.5% | -$6.01K | 0.32% | 67 |
|
|
2014
Q1 | $1.18M | Buy |
38,685
+21,080
| +120% | +$629K | 0.34% | 69 |
|
|
2013
Q4 | $512K | Hold |
17,605
| – | – | 0.12% | 82 |
|
|
2013
Q3 | $480K | Buy |
17,605
+764
| +5% | +$20.8K | 0.13% | 83 |
|
|
2013
Q2 | $448K | Buy |
+16,841
| New | +$465K | 0.13% | 81 |
|
Other funds holding PFE
VCM
VPM
Arcadia Investment Management's PFE Position: Q1 2026 in Review
Arcadia Investment Management increased its Pfizer (PFE) stake by 0.31% in Q1 2026, buying an estimated $319 and bringing the position to 3,912 shares worth $110K. The position accounts for 0.02% of the portfolio, ranked #137.
Arcadia Investment Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.1M in Q2 2016. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Arcadia Investment Management held 3,912 shares of Pfizer worth $110K as of Q1 2026.
- Arcadia Investment Management bought 12 Pfizer shares in Q1 2026, an estimated $319.
- Pfizer made up 0.02% of Arcadia Investment Management's portfolio in Q1 2026, its #137 holding.
- Arcadia Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Arcadia Investment Management's Pfizer position peaked at $2.1M in Q2 2016.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.